Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3048

Actual shortage: 226 (7%)
Anticipated shortage: 14 (0%)
Avoided shortage: 9 (0%)
Resolved: 2799 (92%)

Discontinuation Reports

356

To be discontinued: 22 (6%)
Discontinued: 334 (94%)
Reversed: 0 (0%)

Late reports

142 (4%)

Overdue reports

31 (12%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-METHYLPHENIDATE ER 18MG TABLET (EXTENDED-RELEASE) Resolved 2023-05-06 2023-06-09 191880
APO-DESVENLAFAXINE EXTENDED-RELEASE TABLETS 100MG TABLET (EXTENDED-RELEASE) Resolved 2023-05-06 2023-05-12 191898
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2023-05-19 2023-07-21 192800
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2023-05-19 2023-06-23 192818
APO-DESVENLAFAXINE EXTENDED-RELEASE TABLETS 100MG TABLET (EXTENDED-RELEASE) Resolved 2023-05-26 2023-07-21 193218
APO-OXYCODONE CR 40MG TABLET (EXTENDED-RELEASE) Resolved 2023-06-02 2023-08-12 193614
APO-GLICLAZIDE MR 60MG TABLET (EXTENDED-RELEASE) Resolved 2023-06-09 2023-09-22 194571
APO-FELODIPINE 2.5MG TABLET (EXTENDED-RELEASE) Resolved 2023-06-16 2023-08-04 195091
APO-METHYLPHENIDATE ER 18MG TABLET (EXTENDED-RELEASE) Resolved 2023-06-23 2023-08-23 196297
APO-FELODIPINE 10MG TABLET (EXTENDED-RELEASE) Resolved 2023-06-23 2023-08-04 196300
APO-OXYCODONE CR 80.0MG TABLET (EXTENDED-RELEASE) Resolved 2023-06-23 2023-08-12 196312
APO-FELODIPINE 5MG TABLET (EXTENDED-RELEASE) Resolved 2023-07-21 2023-08-04 199527
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Actual shortage 2023-07-27 2024-03-15 200177
APO-METFORMIN ER 500MG TABLET (EXTENDED-RELEASE) Resolved 2023-08-13 2023-10-15 201719
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2023-08-23 2023-11-06 202824
APO-ALFUZOSIN 10MG TABLET (EXTENDED-RELEASE) Resolved 2023-08-23 2023-09-01 202830
APO-METHYLPHENIDATE ER 18MG TABLET (EXTENDED-RELEASE) Resolved 2023-09-07 2023-10-20 203804
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2023-09-07 2023-09-19 203855
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Actual shortage 2023-09-28 2024-03-15 205480
APO-GLICLAZIDE MR 30MG TABLET (EXTENDED-RELEASE) Resolved 2023-10-06 2024-02-16 206563

Showing 2941 to 2960 of 3048

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-IRBESARTAN/HCTZ Discontinued 2018-02-23 2018-07-17 40763
APO-CETIRIZINE Discontinued 2018-05-31 2018-05-31 50998
APO-AMOXI CLAV 125MG/31.25MG PER 5ML Discontinued 2018-09-07 2018-09-15 60241
APO-CYCLOSPORINE ORAL SOLUTION Discontinued 2018-09-07 2018-09-15 60408
APO-FAMOTIDINE TAB 20MG USP Discontinued 2018-09-07 2018-09-15 60477
APO-FAMOTIDINE TAB 40MG USP Discontinued 2018-09-07 2018-09-15 60480
APO-FENTANYL MATRIX Discontinued 2018-09-07 2018-09-15 60494
APO-IRBESARTAN/HCTZ Discontinued 2018-09-07 2018-09-15 60548
APO-LATANOPROST-TIMOP Discontinued 2018-09-07 2018-09-15 60572
APO-REPAGLINIDE Discontinued 2018-09-08 2018-09-15 60735
APO-REPAGLINIDE Discontinued 2018-09-08 2018-09-15 60738
APO-REPAGLINIDE Discontinued 2018-09-08 2018-09-15 60741
APO-RIZATRIPTAN RPD Discontinued 2018-09-08 2019-04-02 60756
APO-SILDENAFIL R Discontinued 2018-09-08 2018-09-15 60787
APO-AMOXI CLAV 125MG/31.25MG PER 5ML Discontinued 2018-12-21 2018-12-24 70347
APO-TIMOP Discontinued 2019-01-02 2019-01-02 70818
ACID CONTROL Discontinued 2019-01-03 2019-01-03 70906
APO-OFLOXACIN Discontinued 2019-01-03 2019-01-03 71017
APO-TIMOP GEL Discontinued 2019-01-03 2019-01-03 71020
APO-VALSARTAN Discontinued 2019-01-03 2019-01-03 71029

Showing 1 to 20 of 356